TO STUDY THE NATURE OF DISEASE(SYSTEMIC LUPUS ERYTHEMATOSUS)AND ALSO ROLE OF BIOCHEMICAL MARKER( SERUM ADENOSINE DEAMINASE LEVELS) IN RELATION TO SEVERITY OF DISEASE(SYSTEMIC LUPUS ERYTHEMATOSUS)
Not Applicable
- Conditions
- Health Condition 1: M329- Systemic lupus erythematosus, unspecified
- Registration Number
- CTRI/2020/09/028063
- Lead Sponsor
- TUKURU NITHIN KUMAR REDDY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with systemic lupus erythematosus using SLICC
criteria.
Exclusion Criteria
Active TB and previously diagnosed with TB, and autoimmune diseases like rheumatoid arthritis, psoriasis, systemic sclerosis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the association between serum adenosine deaminase levels and <br/ ><br>disease activity of systemic lupus erythematosus.Timepoint: OCTOBER 2021
- Secondary Outcome Measures
Name Time Method 1.To study the clinical profile of systemic lupus erythematosus. <br/ ><br>2.To compare serum adenosine deaminase levels with other conventional markers like <br/ ><br>ESR, CRP, ESR/CRP RATIO, C3, C4, ANTI ds dna, and random urine protein creatinine <br/ ><br>ratio.Timepoint: OCTOBER 2021